Sterling Capital Management LLC Elevation Oncology, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 98 shares of ELEV stock, worth $57. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98Holding current value
$57% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELEV
# of Institutions
82Shares Held
52.8MCall Options Held
700Put Options Held
2.1K-
Goldman Sachs Group Inc New York, NY3.99MShares$2.35 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.85MShares$2.27 Million0.98% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$2.08 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$1.81 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$1.81 Million1.01% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $13.7M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...